CVRxCVRX +11.62%57 Quick Ratio is 8.89 as of Mar. 2026, which is 19% below its 10-year median of 10.94. GuruFocus rates CVRX with a GF Score™ of 57/100 and a GF Value™ of $11.22 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 854 Medical Devices & Instruments companies, CVRx ranks better than 93.09% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. CVRx's quick ratio for the quarter that ended in Mar. 2026 was 8.89.
CVRx has a quick ratio of 8.89. It generally indicates good short-term financial strength.
The historical rank and industry rank for CVRx's Quick Ratio or its related term are showing as below:
CVRX'
s Quick Ratio Range Over the Past 10 Years
Min: 2.04 Med: 10.94 Max: 24.92
Current: 8.89
During the past 7 years, CVRx's highest Quick Ratio was 24.92. The lowest was 2.04. And the median was 10.94.
CVRX's Quick Ratio is ranked better than 93.09% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.865
vs CVRX: 8.89
CVRx (NAS:CVRX) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
CVRx Quick Ratio Related Terms
CVRx Quick Ratio Historical Data
* Premium members only.
The historical data trend for CVRx's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, CVRx's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CVRx Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CVRx's Quick Ratio distribution charts can be found below:
* The bar in red indicates where CVRx's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
CVRx's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVRx (CVRX) has a Quick Ratio of 8.89 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on CVRx and its competitors. This is 19% below median its historical median of 10.94. Over the past decade, CVRx's Quick Ratio has ranged from 2.04 to 24.92. According to the industry distribution chart, CVRx ranks #59 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 6.9%.
Is CVRx's Quick Ratio too high?
CVRx's current Quick Ratio of 8.89 is 19% below median its 10-year median of 10.94. Over the past 10 years, this metric has ranged from a low of 2.04 to a high of 24.92. The Medical Devices & Instruments industry median Quick Ratio is 1.87. CVRx's value of 8.89 is 376.7% above this industry median. Based on the distribution chart, CVRx ranks #59 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, CVRx has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CVRx's Quick Ratio compare to QTRX and SNWV?
According to the Medical Devices & Instruments industry distribution chart, CVRx ranks #59 out of 854 companies for Quick Ratio. This places CVRx in the top 7% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.87. CVRx's value of 8.89 is 376.7% above this benchmark. Historically, CVRx's own Quick Ratio has ranged from 2.04 to 24.92 over the past decade. While the company's 10-year median is 10.94 vs. the industry median of 1.87, CVRx has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CVRx's current Quick Ratio of 8.89 is 376.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on CVRx and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVRx's current Quick Ratio is 8.89, which is 19% below median its own 10-year median of 10.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVRx stock overvalued right now?
Based on GuruFocus' analysis, CVRx (CVRX) is currently considered Possible Value Trap. The stock's GF Value™ is $11.22, compared to a current price of $5.86 — trading 47.8% below its estimated fair value. The current Quick Ratio is 8.89, which is 19% below median its 10-year median of 10.94 and 376.7% above the Medical Devices & Instruments industry median of 1.87. CVRx's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For CVRx (CVRX), the current Quick Ratio is 8.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVRx (CVRX) Overvalued in 2026?
Based on GuruFocus' analysis, CVRx stock appears to be undervalued.
The current stock price of $5.86 is trading 47.8% below its estimated GF Value™ of $11.22.
GuruFocus considers CVRx to be Possible Value Trap.
Key valuation signals for CVRX:
Quick Ratio: 8.89 (19% below median its 10-year median of 10.94)
GF Value™: $11.22 vs. price of $5.86 (47.8% below fair value)
Industry Position: 376.7% above the Medical Devices & Instruments median (#59 of 854)
No single metric tells the full story. See the CVRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
57GF Score
Get the complete analysis for CVRX
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVRX has been successfully added to your 
